# Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis

> **NCT01013259** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 34 (actual)

## Conditions studied

- Rhinoconjunctivitis

## Interventions

- **DRUG:** Mutaflor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01013259
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2009-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013259, "Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01013259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*